Autori: Saito K

Filtra

Data

Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

Torna in alto